检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis who responded at Week 16: Results from the BE BRIGHT open-label extension trial

Bruce Strober,Yayoi Tada,Ulrich Mrowietz,Mark Lebwohl,Peter Foley,Richard G Langley,Jonathan Barker, Maggie Wang,Veerle Vanvoorden, Balint Szilagyi,Valerie Ciaravino,Carle Paul

SKIN The Journal of Cutaneous Medicine（2022）

引用 0|浏览4
暂无评分
摘要
N/A
更多
查看译文
关键词
severe plaque psoriasis,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要